financetom
Business
financetom
/
Business
/
Monster Beverage Q3 sales rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Monster Beverage Q3 sales rise
Nov 6, 2025 1:57 PM

Overview

* Monster Beverage ( MNST ) Q3 net sales rise 16.8%, beating analyst expectations

* Net income for Q3 increases 41.4% to $524.5 mln

* Operating income for Q3 rises 40.7% to $675.4 mln

Outlook

* Company plans to launch FLRT, a female-focused brand, in early 2026

* Monster Beverage ( MNST ) highlights innovation as central to long-term growth strategy

* Company notes increasing consumer demand driving energy drink category growth

Result Drivers

* MONSTER ENERGY DRINKS - Net sales increased 17.7% to $2.03 bln, driven by strong demand for energy drinks

* FOREIGN CURRENCY IMPACT - Favorable exchange rates added $31.8 mln to net sales

* GROSS PROFIT MARGIN - Improved to 55.7% due to pricing actions and supply chain optimization

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Sales Beat $2.20 $2.11

bln bln (16

Analysts

)

Q3 EPS $0.53

Q3 Net $524.46

Income mln

Q3 $549.13

Operatin mln

g

Expenses

Q3 $675.35

Operatin mln

g income

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 14 "strong buy" or "buy", 8 "hold" and 2 "sell" or "strong sell"

* The average consensus recommendation for the non-alcoholic beverages peer group is "hold."

* Wall Street's median 12-month price target for Monster Beverage Corp ( MNST ) is $70.00, about 3% above its November 5 closing price of $67.87

* The stock recently traded at 32 times the next 12-month earnings vs. a P/E of 30 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Investors anxiously await next steps on trade between US and EU
Investors anxiously await next steps on trade between US and EU
Jul 11, 2025
* Pharmaceuticals and autos are key focus areas in US-EU trade talks * Citi strategist warns positive trade developments needed by August 1 to sustain market gains * S&P 500 ends week down 0.3%, near record highs By Lewis Krauskopf NEW YORK, July 11 (Reuters) - Investors awaited tariff news between the U.S. and European Union on Friday that could...
TIMELINE-Key events in the Air India crash investigation
TIMELINE-Key events in the Air India crash investigation
Jul 11, 2025
July 12 (Reuters) - A preliminary report into the Air India crash that killed 260 people last month showed that seconds after taking off, the plane's engines fuel cutoff switches almost simultaneously flipped from run to cutoff, starving the engines of fuel. Following is a timeline of key events in the investigation to date: JUNE 12: An Air India Boeing...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Krystal Biotech Insider Sold Shares Worth $2,122,835, According to a Recent SEC Filing
Krystal Biotech Insider Sold Shares Worth $2,122,835, According to a Recent SEC Filing
Jul 11, 2025
05:47 PM EDT, 07/11/2025 (MT Newswires) -- Krish S Krishnan, 10% Owner, Director, President and CEO, on July 09, 2025, sold 14,127 shares in Krystal Biotech ( KRYS ) for $2,122,835. Following the Form 4 filing with the SEC, Krishnan has control over a total of 3,122,640 common shares of the company, with 1,525,929 shares held directly and 1,596,711 controlled...
Copyright 2023-2026 - www.financetom.com All Rights Reserved